1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with inosine pranobex in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (inosine pranobex) | Trials (inosine pranobex) | Recent Studies (post-2010) (inosine pranobex) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 558 | 111 | 28 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dizdarer, G; Huseyinov, A; Kutukçuler, N; Tekgül, H; Tutuncuoglu, S | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and inosine pranobex
| Article | Year |
|---|---|
Lymphocyte subsets and inflammatory mediators in patients with subacute sclerosing panencephalitis.
Topics: Adjuvants, Immunologic; Adolescent; Antiviral Agents; Child, Preschool; Female; Humans; Inflammation Mediators; Inosine Pranobex; Interferon-alpha; Interleukin-1; Interleukin-2; Lymphocyte Subsets; Male; Platelet Activating Factor; Subacute Sclerosing Panencephalitis; Tumor Necrosis Factor-alpha | 1999 |